Evidence map›Paper›PMID 29212699›Full record

ArticleJournal of clinical microbiology2018

Rapid Microarray-Based Detection of Rifampin, Isoniazid, and Fluoroquinolone Resistance in Mycobacterium tuberculosis by Use of a Single Cartridge.

Juliane Havlicek, Beatrice Dachsel, Peter Slickers, Sönke Andres, Patrick Beckert, Silke Feuerriegel, Stefan Niemann, Matthias Merker, Ines Labugger

Open access · hybridAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Use of reverse dot blot hybridization DNA-array and targeted next-generation sequencing for the detection of drug resistance in patients with tuberculosis: a prospective diagnostic accuracy study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Juliane HavlicekAlere Technologies GmbH, Jena, Germany.
Beatrice DachselAlere Technologies GmbH, Jena, Germany.
Peter SlickersAlere Technologies GmbH, Jena, Germany.
Sönke AndresNational Reference Center for Mycobacteria, Research Center Borstel, Borstel, Germany.
Patrick BeckertMolecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany.
Silke FeuerriegelMolecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany.
Stefan NiemannMolecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany.
Matthias Merker *Molecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany mmerker@fz-borstel.de.
Ines Labugger *Alere Technologies GmbH, Jena, Germany.
Alere (Germany) · DEResearch Center Borstel - Leibniz Lung Center · DEGerman Center for Infection Research · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rapid and robust identification of mutations in

Indexed as

Oligonucleotide Array Sequence AnalysisAntitubercular AgentsBacterial ProteinsDiagnostic Tests, RoutineDrug Resistance, BacterialEswatiniFluoroquinolonesIsoniazidMicrobial Sensitivity TestsMycobacterium tuberculosisPhenotypeReproducibility of ResultsRifampinTime FactorsTuberculosis, Multidrug-ResistantAntitubercular AgentsBacterial ProteinsFluoroquinolonesIsoniazidRifampindiagnosticsMycobacterium tuberculosis

Identifiers

PMID29212699
PMCPMC5786735
OpenAlexW2772403923

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.